Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reissue Patent
2007-07-31
2007-07-31
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S352000, C514S277000, C514S247000, C546S342000, C546S290000, C544S238000, C544S242000, C544S336000, C549S030000, C549S049000, C549S200000, C549S302000, C548S400000, C548S452000, C564S342000
Reissue Patent
active
10640278
ABSTRACT:
The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.
REFERENCES:
patent: 0490667 (1992-06-01), None
patent: 6-179622 (1994-06-01), None
patent: 6-192073 (1994-07-01), None
patent: 6-256181 (1994-09-01), None
patent: 6-305955 (1994-11-01), None
patent: 6-316520 (1994-11-01), None
patent: 7-206765 (1995-08-01), None
patent: 7-258100 (1995-10-01), None
patent: WO 9529152 (1995-11-01), None
patent: 96/21648 (1996-07-01), None
patent: 97/24328 (1997-07-01), None
Chemical Abstracts, vol. 63, No. 13, Dec. 20, 1965, Abstract No. 18311g.
Chemical Abstracts, vol. 119, No. 25, Dec. 20, 1993, Abstract No. 270986n.
Yurin Mittin et al, “Rearrangement of Ortho-O-Aminoacycl,N-Acylaminophenol,” Tetrahedron Letters, No. 12, pp. 1081-1084, 1979.
Inge Olsson et al, “Induction of Differentiation of the Human Histiocytic Lymphoma Cell Line U-937 by 1α,25-Dihydroxycholecalciferol,” Cancer Research, vol. 43, 1983, pp. 5862-5867.
Raymond P. Warrell, Jr., M.D., et al, “Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-Trans-Retinoic Acid),” The New England Journal of Medicine, vol. 324, No. 20, 1991, pp. 1385-1393.
Sylvie Castaigne et al, “All-Trans Retinoic Acid as a Differentiation Therapy for Acute Promyelocytic Leukemia. I. Clinical Results,” Blood, vol. 76, No. 9, 1990, pp. 1704-1709.
Huang Meng-er et al, “Use of All-Trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia,” Blood, vol. 72, No. 2, 1988, pp. 567-572.
Matthew Clark et al, “Validation of the General Purpose Tripos 5.2 Force Field,” Journal of Computational Chemistry, vol. 10, No. 8, 1989, pp. 982-1012.
Chemical Abstracts, vol. 63, No. 13, Dec. 20, 1995, Columbus, OH, US; Abstract No. 18311g, B.S. Portnaya et al; XP002051609 & Zhurnal Nauchnoi I Prikladnoi Fotografii I Kinematografi, vol. 10, No. 4, 1965 Moscow ISSN 0044-4561, pp. 278-287.
Chemical Abstracts, vol. 119, No. 25, Dec. 20, 1993, Columbus, OH, US; Abstract No. 270986n, J. Nowakowski: XP002051610 & PL 157 443 B (Uniwersytet Mikolaja Kopernika).
Y.V. Mitin et al., “Rearrangement of ortho-O-aminoacyl, N-acylaminophenol”, Tetrahedron Letters, No. 12, 1979, Oxford GB, pp. 1081-1084, XP002051608.
H. Meng-er et al, “Use of All-Trans Retinoic Acid in the Treatment of acute prymyelocytic Leukemia”,Blood,vol. 72, No. 2, Aug. 1988, pp. 567-572.
S. Castaigne et al, “All-Trans Tetinoic Acid as a Differentiation Therapy for Acute Promyelocytic Leukemia. I. Clinical Results”,Blood,vol. 76, No. 9, Nov. 1990, pp. 1704-1709.
R. Warrell, Jr., “Differentiation Therapy of Acute Promyelocytic Leukemia With Tretinoin (All-Trans-Retinoic Acid”,The New England Journal of Medicine,vol. 324, No. 20, May 1991, pp. 1385-1393.
I. Olsson et al, “Introduction of Differentiation of the Human Histiocyctic Lymphoma Cell Line U-937 b 1α, 25-Dihydroxycholecalciferol”,Cancer Research,vol. 43, Dec. 1983, pp. 5862-5867.
M. Clark et al, “Validation of the General Purpose Tripos 5.2 Force Field”,Journal of Computational Chemistry,vol. 10, No. 8, 1989, pp.982-1012.
Ando Tomoyuki
Nakanishi Osamu
Saito Akiko
Shiraishi Yoshinori
Suzuki Tsuneji
Buchanan & Ingersoll & Rooney PC
Desai Rita
Schering AG
LandOfFree
Benzamide derivatives and pharmaceutical compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzamide derivatives and pharmaceutical compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzamide derivatives and pharmaceutical compositions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3811224